Rosa Bacchetta

Title: Rosa Bacchetta: Innovator in Epigenetic Research

Introduction

Rosa Bacchetta is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of epigenetics, particularly in the detection and differentiation of immunodysregulation syndromes. With a total of 5 patents, her work has the potential to impact newborn health and treatment options.

Latest Patents

Bacchetta's latest patents include an epigenetic method to detect and distinguish IPEX and IPEX-like syndromes, especially in newborns. This invention focuses on identifying IPEX syndrome using the methylation status of FOXP3 and a control gene specific for CD4 and/or CD3 T cells. The method is crucial for distinguishing IPEX from IPEX-like and unrelated disorders. Additionally, she has developed a self-inactivating lentiviral vector comprising a FOXP3 expression cassette. This vector utilizes endogenous gene elements to regulate the physiological expression of FoxP3, showcasing her innovative approach to gene therapy.

Career Highlights

Throughout her career, Bacchetta has worked with esteemed institutions such as Leland Stanford Junior University and Precision for Medicine GmbH. Her research has been pivotal in advancing our understanding of genetic disorders and their treatment.

Collaborations

Rosa Bacchetta has collaborated with notable professionals in her field, including Sven Olek and Donald B. Kohn. These partnerships have further enriched her research and contributed to her innovative projects.

Conclusion

Rosa Bacchetta's contributions to epigenetic research and her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in the detection and treatment of genetic disorders.